認知障害:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Cognitive Impairment Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cognitive Impairment 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cognitive Impairment 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Cognitive Impairment Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Johnson & Johnson 38
Clinical Trial Overview of Johnson & Johnson 38
Eli Lilly and Company 39
Clinical Trial Overview of Eli Lilly and Company 39
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
Eisai Co., Ltd. 41
Clinical Trial Overview of Eisai Co., Ltd. 41
AbbVie Inc. 42
Clinical Trial Overview of AbbVie Inc. 42
Takeda Pharmaceutical Company Limited 43
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 43
Shire Plc 44
Clinical Trial Overview of Shire Plc 44
GlaxoSmithKline plc 45
Clinical Trial Overview of GlaxoSmithKline plc 45
Clinical Trial Overview of Top Institutes / Government 46
U.S. Department of Veterans Affairs 46
Clinical Trial Overview of U.S. Department of Veterans Affairs 46
University of Washington 47
Clinical Trial Overview of University of Washington 47
Charite – Universitatsmedizin Berlin 48
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 48
University Hospital Basel 49
Clinical Trial Overview of University Hospital Basel 49
National Institute on Aging 50
Clinical Trial Overview of National Institute on Aging 50
Vanderbilt University 51
Clinical Trial Overview of Vanderbilt University 51
University of Pennsylvania 52
Clinical Trial Overview of University of Pennsylvania 52
Emory University 53
Clinical Trial Overview of Emory University 53
University Hospital, Angers 54
Clinical Trial Overview of University Hospital, Angers 54
National Institute of Mental Health 55
Clinical Trial Overview of National Institute of Mental Health 55
Five Key Clinical Profiles 56
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 106


【レポート販売概要】

■ タイトル:認知障害:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Cognitive Impairment Global Clinical Trials Review, H1, 2014
■ 発行日:2014年6月20日
■ 調査会社:GlobalData
■ 商品コード:GDHC2204CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。